Survival Benefit in Myeloma With Lenalidomide Maintenance After Transplant
Patients with newly diagnosed multiple myeloma treated with lenalidomide maintenance therapy after undergoing autologous stem-cell transplantation had significantly improved overall survival compared with observation or placebo.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Leah Lawrence Tags: Hematologic Malignancies Multiple Myeloma News Source Type: news
More News: Cancer & Oncology | Hematology | Legislation | Myeloma | Revlimid | Stem Cell Therapy | Stem Cells | Transplants